| Type of Biological Sample |
Components / Analytes |
Examination Technique |
Examination Procedure |
Status |
| Genetics & Molecular & Cyto Genetics |
| - Pathogenetic somatic variant and gene fusions analysis and interpretation by Next generation sequencing: ABL1, CDK12, EZH2, MAP2K1, PDGFRA, RAD51B, TSC2, ALK, CDK4, FANCL, MAP2K2, PDGFRB
| - Next Generation Sequencing
| ILS-GS-SOP-009 Targt First Blood | Active
|
| - Pathogenetic somatic variant and gene fusions analysis and interpretation by Next generation sequencing: RAD51C, APC, CDK6, FGFR1, MDM2, PIK3CA, RAD51D, AR, CDKN2A, FGFR2, MET, PMS1, RAD54L, ATM, CHEK1, FGFR3, MLH1, PMS2, RB1, BARD1, CHEK2, GAPDH, MLH3, POLD1, RET, BMPR1A, CTNNB1
| ILS-GS-SOP-022 Targt First Liquid (Cell Free DNA) | Active
|
- Pathogenetic somatic variant and gene fusions analysis and interpretation by Next generation sequencing: IDH1, MSH2, POLE, ROS1, BRAF, EGFR, IDH2, MSH6, POLH, SMAD4, BRCA1, EPCAM, JAK2, MUTYH, PTEN, STK11, BRCA2, ERBB2, KIT, NRAS, RAD50, TP53, BRIP1, ERBB3, KRAS
| ILS-GS-SOP-022 Targt First Liquid (Cell Free DNA) | Active
|
- Pathogenetic somatic variant and gene fusions analysis and interpretation by Next generation sequencing: PALB2, RAD51, TSC1, PALB2, RAD51, TSC1 Gene Fusion: ALK, FGFR2, FGFR3, MET, ROS1, RET, NTRK1, NTRK2, NTRK3, NRG1, NRG2
| ILS-GS-SOP-022 Targt First Liquid (Cell Free DNA) | Active
|
- Formalin-Fixed Paraffin-Embedded DNA
| - Pathogenetic somatic variant and gene fusions analysis and interpretation by Next generation sequencing: ABL1, CDK12, EZH2, MAP2K1, PDGFRA, RAD51B, TSC2, ALK, CDK4, FANCL, MAP2K2, PDGFRB, RAD51C, APC, CDK6, FGFR1, MDM2, PIK3CA, RAD51D, AR, CDKN2A, FGFR2, MET, PMS1
| ILS-GS-SOP-010 Targt First Tissue | Active
|
- Pathogenetic somatic variant and gene fusions analysis and interpretation by Next generation sequencing: RAD54L, ATM, CHEK1, FGFR3, MLH1, PMS2, RB1, BARD1, CHEK2, GAPDH, MLH3, POLD1, RET, BMPR1A, CTNNB1, IDH1, MSH2, POLE, ROS1, BRAF, EGFR, IDH2, MSH6, POLH, SMAD4
| ILS-GS-SOP-010 Targt First Tissue | Active
|
- Pathogenetic somatic variant and gene fusions analysis and interpretation by Next generation sequencing: BRCA1, EPCAM, JAK2, MUTYH, PTEN, STK11, BRCA2, ERBB2, KIT, NRAS, RAD50, TP53, BRIP1, ERBB3, KRAS, PALB2, RAD51, TSC1
| ILS-GS-SOP-010 Targt First Tissue | Active
|
- Pathogenetic somatic variant and gene fusions analysis and interpretation by Next generation sequencing: Gene Fusion: ALK, FGFR2, FGFR3, MET, ROS1, RET, NTRK1, NTRK2, NTRK3, NRG1, NRG2
| ILS-GS-SOP-010 Targt First Tissue | Active
|
